These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 6785318)
1. Potential risk of prolonged administration of stimulant medication for hyperactive children. Satterfield JH; Schell AM; Barb SD J Dev Behav Pediatr; 1980 Sep; 1(3):102-7. PubMed ID: 6785318 [TBL] [Abstract][Full Text] [Related]
2. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)]. Stasik D; Tucha O; Tucha L; Walitza S; Lange KW Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788 [TBL] [Abstract][Full Text] [Related]
3. Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention-deficit/hyperactivity disorder: 2-year, open-label study results. Wigal SB; Wilens TE; Wolraich M; Lerner M Pediatrics; 2007 Jul; 120(1):e120-8. PubMed ID: 17548486 [TBL] [Abstract][Full Text] [Related]
4. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications. Varley CK; Vincent J; Varley P; Calderon R Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243 [TBL] [Abstract][Full Text] [Related]
5. Medication compliance in hyperactive children. Kauffman RE; Smith-Wright D; Reese CA; Simpson R; Jones F Pediatr Pharmacol (New York); 1981; 1(3):231-7. PubMed ID: 7346742 [TBL] [Abstract][Full Text] [Related]
6. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication. Schertz M; Adesman AR; Alfieri NE; Bienkowski RS Pediatrics; 1996 Oct; 98(4 Pt 1):763-9. PubMed ID: 8885958 [TBL] [Abstract][Full Text] [Related]
7. Effects of once-daily osmotic-release methylphenidate on blood pressure and heart rate in children with attention-deficit/hyperactivity disorder: results from a one-year follow-up study. Wilens TE; Biederman J; Lerner M; J Clin Psychopharmacol; 2004 Feb; 24(1):36-41. PubMed ID: 14709945 [TBL] [Abstract][Full Text] [Related]
8. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit]. Bricard C; Boidein F Encephale; 2001; 27(5):435-43. PubMed ID: 11760693 [TBL] [Abstract][Full Text] [Related]
9. [Medication for ADHD and the risk of cardiovascular mortality]. Langendijk PN; Wilde AA Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1713-4. PubMed ID: 16924941 [TBL] [Abstract][Full Text] [Related]
10. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study. Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731 [TBL] [Abstract][Full Text] [Related]
11. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials. Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143 [TBL] [Abstract][Full Text] [Related]
12. Stimulant medication and the hyperactive adolescent: myths and facts. Clampit MK; Pirkle JB Adolescence; 1983; 18(72):811-22. PubMed ID: 6666706 [TBL] [Abstract][Full Text] [Related]
13. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137 [TBL] [Abstract][Full Text] [Related]
14. Does extended medication with amphetamine or methylphenidate reduce growth in hyperactive children? Sund AM; Zeiner P Nord J Psychiatry; 2002; 56(1):53-7. PubMed ID: 11869467 [TBL] [Abstract][Full Text] [Related]
15. Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study. Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Jacobsen SJ J Dev Behav Pediatr; 2007 Aug; 28(4):274-87. PubMed ID: 17700079 [TBL] [Abstract][Full Text] [Related]
16. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder. Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962 [TBL] [Abstract][Full Text] [Related]
17. Exercise responses in boys with attention deficit/hyperactivity disorder: effects of stimulant medication. Mahon AD; Stephens BR; Cole AS J Atten Disord; 2008 Sep; 12(2):170-6. PubMed ID: 17998414 [TBL] [Abstract][Full Text] [Related]
19. Teacher response to the methylphenidate (ritalin) versus placebo status of hyperactive boys in the classroom. Whalen CK; Henker B; Dotemoto S Child Dev; 1981 Sep; 52(3):1005-14. PubMed ID: 7026186 [TBL] [Abstract][Full Text] [Related]
20. Cytogenetic effects in children treated with methylphenidate. El-Zein RA; Abdel-Rahman SZ; Hay MJ; Lopez MS; Bondy ML; Morris DL; Legator MS Cancer Lett; 2005 Dec; 230(2):284-91. PubMed ID: 16297714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]